India Glycols Limited (IN:INDIAGLYCO)
:INDIAGLYCO
Want to see IN:INDIAGLYCO full AI Analyst Report?
INDIAGLYCO Stock Chart & Stats
₹1007.65
-₹68.05(-5.10%)
At close: 4:00 PM EST
₹1007.65
-₹68.05(-5.10%)
Day’s Range― - ―
52-Week Range₹793.95 - ₹1,222.85
Previous CloseN/A
Volume301.52K
Average Volume (3M)19.23K
Market Cap
₹63.10B
Enterprise Value₹81.76B
Total Cash (Recent Filing)₹1.53B
Total Debt (Recent Filing)₹20.55B
Price to Earnings (P/E)21.5
Beta1.50
Next Earnings
Aug 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.47%
Share Statistics
EPS (TTM)41.86
Shares Outstanding67,026,764
10 Day Avg. Volume24,007
30 Day Avg. Volume19,229
Financial Highlights & Ratios
PEG Ratio0.80
Price to Book (P/B)1.84
Price to Sales (P/S)1.28
P/FCF Ratio-31.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)76.05
Revenue Forecast (FY)₹45.78B
Bulls Say, Bears Say
Bulls Say
Renewable Feedstock Business ModelIndia Glycols’ focus on bio-based glycols and specialty chemicals from renewable feedstocks (eg. molasses) represents a durable structural advantage. It aligns the company with long-term sustainability trends and diversifies feedstock exposure away from purely petrochemical inputs, supporting resilience and customer demand in green formulations.
Consistent Revenue GrowthMulti-year top-line growth demonstrates durable market traction across its glycols, glycol ethers and specialty segments. Consistent revenue expansion supports scale economics, underpins investment capacity for higher-value specialty products, and reduces reliance on any single-cycle demand spike.
Improving Leverage And Balance Sheet TrajectoryA marked reduction in debt-to-equity signals improving financial flexibility and lower refinancing pressure. For a chemicals manufacturer with capital intensity, declining leverage enhances capacity to fund working capital, invest in specialty capabilities, and better withstand industry cyclicality over the medium term.
Bears Say
Persistent Negative Free Cash FlowDespite stronger operating cash flow, recurring negative free cash flow is a durable concern: multi-year cash outflows after capex limit the company’s ability to self-fund growth, pay down absolute debt, or build reserves. Weak cash conversion relative to profits raises questions on earnings quality and financial flexibility.
Marked Gross Margin CompressionA severe decline in gross margins over several years indicates sustained pressure from input costs, product mix shifts, or pricing dynamics. Lower gross margins reduce buffer for SG&A and R&D, increasing sensitivity of profitability to volume swings and constraining reinvestment into higher-margin specialty offerings.
Moderate Returns And Residual Balance Sheet RiskROE around 10% signals only modest capital efficiency versus peers; combined with absolute debt remaining meaningful, this limits the company’s margin for error. If cash generation does not sustainably improve, balance sheet risks and constrained returns could hamper strategic investments and shareholder value creation.
India Glycols Limited News
INDIAGLYCO FAQ
What was India Glycols Limited’s price range in the past 12 months?
India Glycols Limited lowest stock price was ₹793.95 and its highest was ₹1222.85 in the past 12 months.
What is India Glycols Limited’s market cap?
India Glycols Limited’s market cap is ₹63.10B.
When is India Glycols Limited’s upcoming earnings report date?
India Glycols Limited’s upcoming earnings report date is Aug 11, 2026 which is in 59 days.
How were India Glycols Limited’s earnings last quarter?
India Glycols Limited released its earnings results on May 14, 2026. The company reported ₹13 earnings per share for the quarter, beating the consensus estimate of N/A by ₹13.
Is India Glycols Limited overvalued?
According to Wall Street analysts India Glycols Limited’s price is currently Overvalued.
Does India Glycols Limited pay dividends?
India Glycols Limited pays a Annually dividend of ₹7.5 which represents an annual dividend yield of 0.47%. See more information on India Glycols Limited dividends here
What is India Glycols Limited’s EPS estimate?
India Glycols Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does India Glycols Limited have?
India Glycols Limited has 67,026,764 shares outstanding.
What happened to India Glycols Limited’s price movement after its last earnings report?
India Glycols Limited reported an EPS of ₹13 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.617%.
Which hedge fund is a major shareholder of India Glycols Limited?
Currently, no hedge funds are holding shares in IN:INDIAGLYCO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
India Glycols Limited
India Glycols Limited (IGL) is an Indian "green petrochemical" enterprise dedicated to the manufacturing and distribution of an extensive array of industrial chemicals. Its operations are segmented across Industrial Chemical, Ethyl Alcohol, and Nutraceuticals divisions. The company's diverse product range features various glycols, including monoethylene, diethylene, triethylene, and polyethylene glycols, alongside numerous ethoxylates such as fatty alcohol, acid, amine, alkyl phenol, castor/natural oil, and ethoxylated/propoxylated co-polymers. IGL also provides polysorbates, glycol ethers and acetates, performance chemicals, brake fluids, and anti-freeze coolants. Furthermore, IGL supplies natural gums like guar gums and other hydrocolloid derivatives. Its alcohol-based offerings include extra neutral alcohols/rectified spirits, Indian-made foreign liquor, and alcohol-based hand sanitizers. The nutraceutical portfolio consists of natural active pharmaceutical ingredients (APIs), standardized botanical/herbal extracts, and spice extracts. Additionally, the company produces industrial gases such as liquid oxygen, argon, nitrogen, and carbon dioxide, as well as specialized IGL Steri-gas ethylene oxide and carbon dioxide mixtures. India Glycols Limited serves a wide spectrum of industries, including agrochemical, automotive, detergent, healthcare, food processing, mining, oil and gas, paper, personal care, pharmaceutical, paint and emulsion polymerization, and textile sectors. The company also actively engages in exporting its products. Originally founded in 1983 as UP Glycols Limited, the company was rebranded as India Glycols Limited in August 1986. It maintains its headquarters in Noida, India.
Technical Analysis
Deepak Nitrite Limited
―
Gujarat Fluorochemicals Ltd.
―
Godavari Biorefineries Limited
―
Gulshan Polyols Limited
―
Navin Fluorine International Limited
―